Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen.

Slides:

Advertisements

Similar presentations

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Development of a Novel Echocardiography Ramp Test.

Advertisements

Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):

Jennifer A. Cowger, MD, Matthew A

Circ Arrhythm Electrophysiol

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention

Circ Cardiovasc Qual Outcomes

Forecasting the Impact of Heart Failure in the United States

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

by Andreia Biolo, Sujata Ramamurthy, Lawreen H. Connors, Carl J

Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.

Attenuation of the “White-Coat Effect” by Antihypertensive Treatment and Regression of Target Organ Damage by Gianfranco Parati, Luisa Ulian, Lorena Sampieri,

Regulation of Circulating Progenitor Cells in Left Ventricular DysfunctionClinical Perspective by Barry A. Boilson, Katarina Larsen, Adriana Harbuzariu,

Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart FailureClinical Perspective by Satoshi.

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

CYB561 homology modeling. CYB561 homology modeling.A, Close-up of mutation G88R in CYB561. The protein is shown in ribbon presentation in gray, the heme.

Circ Cardiovasc Interv

Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing.

Vascular Progenitor Cells in Diabetes Mellitus

Epicardial Catheter Ablation Through Subxiphoid Surgical Approach in a Patient With Implanted Left Ventricular Assist Device and Cannula-Related Ventricular.

Percutaneous Circulatory Support for Biventricular Failure

Circ Arrhythm Electrophysiol

by Katie Ayers, Loretta M. Byrne, Anthony DeMatteo, and Nancy J. Brown

Site Selection and Performance in Clinical Trials

Behavior and Biology: The Basic Sciences for AHA Action

A, Breakdown of frailty into its underlying causes, manifestations, and clinical outcomes separated by LVAD-responsive and LVAD-independent causes of frailty.

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Left Ventricular Assist Device Outflow Cannula Obstruction Treated With Percutaneous Endovascular Stenting by Jacob Abraham, Joshua D. Remick, Todd Caulfield,

Contribution of Stroke to the Cochrane Stroke Group Trials Register

Arterioscler Thromb Vasc Biol

Myocarditis Associated With Campylobacter Enteritis: Report of Three Cases by Dries De Cock, Nick Hiltrop, Philippe Timmermans, Steven Dymarkowski, and.

Virtual Reality in Stroke Rehabilitation

Statin Treatment and Functional Outcome After Ischemic Stroke

Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary.

Age-Related Differences in Phosphodiesterase Activity and Effects of Chronic Phosphodiesterase Inhibition in Idiopathic Dilated CardiomyopathyCLINICAL.

Slowing of ventricular rate (VR) associated with inferior vena cava–inferior atrial ganglionated plexus nerve activity (IVC-IAGPNA) discharge without right.

Box plot showing percentage change in early diastolic pulsed-Doppler mitral inflow (E)/early diastolic tissue Doppler velocity (E´) from pre– to post–balloon.

Blood Pressure and Adverse Events During Continuous Flow Left Ventricular Assist Device SupportCLINICAL PERSPECTIVE by Omar Saeed, Rita Jermyn, Faraj Kargoli,

Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke by Valérie Wolff, Boris Aleil, Maurice Giroud, Jean-Louis Lorenzini,

Effect of intervention on diastolic function.

by Parag C. Patel, Colby R. Ayers, Sabina A

Mathematical representation of Bayes theorem.

Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.

Circ Cardiovasc Qual Outcomes

Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,

Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening by Jonathan M. Sorof, Jennifer Turner,

The Process of Rehabilitation and Discharge Planning in Stroke

by Peter J. Schwartz, Maria Teresa La Rovere, Gaetano M

Percutaneous Intervention for Recurrent Aortic Insufficiency in a Patient With a Left Ventricular Assist Device and a Centrally Oversewn Aortic Valve by.

Clinical Practice Guidelines for Vascular Access

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy Francis D Pagani, MD, PhD, Keith D Aaronson, MD, David B Dyke,

How I treat catastrophic thrombotic syndromes

Jan D. Schmitto, MD, PhD, Jasmin S

Robert C. Neely, MD, Robert Patrick Davis, PhD, Elizabeth H

Richard J. Kaplon, MDa, Mehmet C. Oz, MDa, Pawel A

Sharven Taghavi, MD, MPH, Charisse Ward, MD, Senthil N

Implantation of a left ventricular assist device, back-to-front, in an adolescent with a failing mustard procedure Lars Wiklund, MD, PhD, Sveneric Svensson,

Tomasz A. Timek, MD, Robert L

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Navin K. Kapur, MD, Jenica Upshaw, MD, Michael S

Successful ventricular tachycardia ablation in a patient with a biventricular ventricular assist device and heparin-induced thrombocytopenia using bivalirudin

Volume 72, Issue 5, Pages (November 1977)

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.

Hari R. Mallidi, MD The Journal of Thoracic and Cardiovascular Surgery

Presentation transcript:

Treatment of Left Ventricular Assist Device Thrombosis With Extended Catheter-Directed Intraventricular Thrombolytic Therapy by Thenappan Thenappan, Allen S. Anderson, Valluvan Jeevanadham, Jonathan D. Rich, and Atman P. Shah Circ Heart Fail Volume 6(3):e27-e29 May 21, 2013 Copyright © American Heart Association, Inc. All rights reserved.

Chest x-ray showing the pigtail catheter and the left ventricular assist device inflow cannula in the left ventricular cavity. Chest x-ray showing the pigtail catheter and the left ventricular assist device inflow cannula in the left ventricular cavity. Thenappan Thenappan et al. Circ Heart Fail. 2013;6:e27-e29 Copyright © American Heart Association, Inc. All rights reserved.

Comparison of serum lactate dehydrogenase (LDH), bilirubin, and creatinine pre- and postfibrinolytic therapy. Comparison of serum lactate dehydrogenase (LDH), bilirubin, and creatinine pre- and postfibrinolytic therapy. AC indicates anticoagulation therapy (intravenous heparin); AP, antiplatelet therapy (intravenous eptifibatide), and TPA, tissue-type plasminogen activator (alteplase). Blue represents case 1 and red represents case 2. Thenappan Thenappan et al. Circ Heart Fail. 2013;6:e27-e29 Copyright © American Heart Association, Inc. All rights reserved.